To further validate the two molecules screened in the prescreening, we first assessed the expression level of GRASLND in melanoma and normal tissues by qRT–PCR, and the results showed that its expression was significantly upregulated in SKCM (Fig. 2A). The gene discussed is GRASLND; the disease is melanoma.